{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:52:54Z","timestamp":1792144374875,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015688","name":"\u00d3buda University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015688","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Aims<\/jats:title>\n            <jats:p>Albuminuria within the normal range may predict an increased risk of subsequent nephropathy in type 1 diabetes (T1D). The role of sustained hyperglycaemia in the development of nephropathy is well-known. The relationship between albuminuria within the normal range and parameters of continuous glucose monitoring (CGM) in childhood has not yet been investigated. The aim of the present study was to analyze this relationship in young T1D patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 54 normoalbuminuric, normotensive, real time CGM user pubertal children and adolescents with T1D were recruited for this study. Patients with medium to high normal (1.0-2.9\u00a0mg\/mmol; <jats:italic>n<\/jats:italic>\u2009=\u200918) and those with low normal (&lt;\u20091.0\u00a0mg\/mmol; <jats:italic>n<\/jats:italic>\u2009=\u200936) urinary albumin-to-creatinin ratio (UACR) were compared regarding CGM metrics data. Relationships of UACR with clinical variables and CGM-derived metrics were analysed by multiple logistic regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Time in range (TIR) was lower in medium to high normal UACR patients than in low normal UACR patients (mean\u2009\u00b1\u2009SD: 58.2\u2009\u00b1\u20098.4% vs. 64.5\u2009\u00b1\u200910.1%, <jats:italic>p<\/jats:italic>\u2009=\u20090.0199). Patients with medium to high normal UACR had a higher coefficient of variation for mean glucose (CV) than those with low normal UACR (42.4\u2009\u00b1\u20096.0% vs. 38.0\u2009\u00b1\u20096.1%, <jats:italic>p<\/jats:italic>\u2009=\u20090.0163). UACR was related to TIR (<jats:italic>r<\/jats:italic>=-0.55, <jats:italic>p<\/jats:italic>\u2009=\u20090.02), to CV (<jats:italic>r<\/jats:italic>=-0.51, <jats:italic>p<\/jats:italic>\u2009=\u20090.04) and to mean glucose (MG) (<jats:italic>r<\/jats:italic>=-0.48, <jats:italic>p<\/jats:italic>\u2009=\u20090.05). TIR, CV and puberty proved to be independently predictive for medium to high normal UACR [adjusted RR (95% CI): 0.70 (0.58\u20130.92), <jats:italic>p<\/jats:italic>\u2009=\u20090.0231; 1.28 (1.02\u20131.67), <jats:italic>p<\/jats:italic>\u2009=\u20090.0222; 1.19 (1.10\u20131.36), <jats:italic>p<\/jats:italic>\u2009=\u20090.0321, respectively].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The duration of the blood glucose level within the target range and the extent of its fluctuation may contribute to the early increase in albumin excretion within the normal range, which may play a role in the development of later complications of childhood T1D.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13098-025-01749-x","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T01:32:04Z","timestamp":1748223124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between urinary albumin-to-creatinine ratio within the normal range and continuous glucose monitoring-derived metrics in children and adolescents with type 1 diabetes"],"prefix":"10.1186","volume":"17","author":[{"given":"L\u00e1szl\u00f3","family":"Barkai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliv\u00e9r","family":"R\u00e1cz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Eigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levente","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"1749_CR1","doi-asserted-by":"publisher","unstructured":"Bjornstad P, Dart A, Donaghue KC, Dost A, Feldman EL, Tan GS, Wadwa RP, Zabeen B, Marcovecchio ML. ISPAD Clinical Practice Consensus Guidelines 2022: Microvascular and macrovascular complications in children and adolescents with diabetes. Pediatr Diabetes. 2022;23(8):1432\u20131450. https:\/\/doi.org\/10.1111\/pedi.13444. PMID: 36537531.","DOI":"10.1111\/pedi.13444"},{"issue":"8","key":"1749_CR2","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.2337\/diacare.28.8.1974","volume":"28","author":"F Mohsin","year":"2005","unstructured":"Mohsin F, Craig ME, Cusumano J, Chan AK, Hing S, Lee JW, Silink M, Howard NJ, Donaghue KC. Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002. Diabetes Care. 2005;28(8):1974\u201380. https:\/\/doi.org\/10.2337\/diacare.28.8.1974.","journal-title":"Diabetes Care"},{"issue":"11","key":"1749_CR3","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.2337\/dc11-0102","volume":"34","author":"E Downie","year":"2011","unstructured":"Downie E, Craig ME, Hing S, Cusumano J, Chan AK, Donaghue KC. Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control. Diabetes Care. 2011;34(11):2368\u201373. https:\/\/doi.org\/10.2337\/dc11-0102.","journal-title":"Diabetes Care"},{"issue":"5","key":"1749_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jpeds.2009.05.025","volume":"155","author":"DB Petitti","year":"2009","unstructured":"Petitti DB, Klingensmith GJ, Bell RA, Andrews JS, Dabelea D, Imperatore G, Marcovina S, Pihoker C, Standiford D, Waitzfelder B, Mayer-Davis E, SEARCH for Diabetes in Youth Study Group. Glycemic control in youth with diabetes: the SEARCH for diabetes in youth study. J Pediatr. 2009;155(5):668\u201372.e1-3. https:\/\/doi.org\/10.1016\/j.jpeds.2009.05.025.","journal-title":"J Pediatr"},{"issue":"7646","key":"1749_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1136\/bmj.39478.378241.BE","volume":"336","author":"R Amin","year":"2008","unstructured":"Amin R, Widmer B, Prevost AT, et al. Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ. 2008;336(7646):697\u2013701. https:\/\/doi.org\/10.1136\/bmj.39478.378241.BE.","journal-title":"BMJ"},{"issue":"3","key":"1749_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/s0022-3476(99)70459-2","volume":"134","author":"D Gorman","year":"1999","unstructured":"Gorman D, Sochett E, Daneman D. The natural history of microalbuminuria in adolescents with type 1 diabetes. J Pediatr. 1999;134(3):333\u20137. https:\/\/doi.org\/10.1016\/s0022-3476(99)70459-2.","journal-title":"J Pediatr"},{"issue":"9854","key":"1749_CR7","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/s0140-6736","volume":"380","author":"CS Fox","year":"2012","unstructured":"Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (London England). 2012;380(9854):1662\u201373. https:\/\/doi.org\/10.1016\/s0140-6736.","journal-title":"Lancet (London England)"},{"issue":"5","key":"1749_CR8","doi-asserted-by":"publisher","first-page":"E924","DOI":"10.1152\/ajpendo.2001.281.5.E924","volume":"281","author":"A Risso","year":"2001","unstructured":"Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab. 2001;281(5):E924\u201330. https:\/\/doi.org\/10.1152\/ajpendo.2001.281.5.E924.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"1749_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1089\/dia.2013.0205","volume":"16","author":"J \u0160oupal","year":"2014","unstructured":"\u0160oupal J, \u0160krha J, Fajmon M, Horov\u00e1 E, Mr\u00e1z M, \u0160krha J, et al. Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control. Diabetes Technol Ther. 2014;16(4):198\u2013203. https:\/\/doi.org\/10.1089\/dia.2013.0205.","journal-title":"Diabetes Technol Ther"},{"key":"1749_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.annepidem.2020.12.004","volume":"Mar","author":"K Inoue","year":"2021","unstructured":"Inoue K, Streja E, Tsujimoto T, Kobayashi H. Urinary albumin-to-creatinine ratio within normal range and all-cause or cardiovascular mortality among U.S. Adults enrolled in the NHANES during 1999\u20132015. Ann Epidemiol. 2021;Mar:55\u201315. https:\/\/doi.org\/10.1016\/j.annepidem.2020.12.004.","journal-title":"Ann Epidemiol"},{"key":"1749_CR11","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42:1593\u2013603. https:\/\/doi.org\/10.2337\/dci19-0028.","journal-title":"Diabetes Care"},{"issue":"12","key":"1749_CR12","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.2337\/diacare.23.12.1811","volume":"23","author":"CJ Schultz","year":"2000","unstructured":"Schultz CJ, Neil HA, Dalton RN, Dunger DB. Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type 1 diabetes. Diabetes Care. 2000;23(12):1811\u20135. https:\/\/doi.org\/10.2337\/diacare.23.12.1811.","journal-title":"Diabetes Care"},{"issue":"6","key":"1749_CR13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2337\/dc16-2426","volume":"40","author":"JM Lachin","year":"2017","unstructured":"Lachin JM, Bebu I, Bergenstal RM, Pop-Busui R, Service FJ, Zinman B, Nathan DM, DCCT\/EDIC Research Group. Association of glycemic variability in type 1 diabetes with progression of microvascular outcomes in the diabetes control and complications trial. Diabetes Care. 2017;40(6):777\u201383. https:\/\/doi.org\/10.2337\/dc16-2426.","journal-title":"Diabetes Care"},{"issue":"11","key":"1749_CR14","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.2337\/dc20-0909","volume":"43","author":"AG Ranjan","year":"2020","unstructured":"Ranjan AG, Rosenlund SV, Hansen TW, Rossing P, Andersen S, N\u00f8rgaard K. Improved time in range over 1 year is associated with reduced albuminuria in individuals with Sensor-Augmented insulin Pump\u2013Treated type 1 diabetes. Diabetes Care. 2020;43(11):2882\u20135. https:\/\/doi.org\/10.2337\/dc20-0909.","journal-title":"Diabetes Care"},{"key":"1749_CR15","doi-asserted-by":"publisher","first-page":"669954","DOI":"10.3389\/fendo.2021.669954","volume":"12","author":"L Mamilly","year":"2021","unstructured":"Mamilly L, Mastrandrea LD, Mosquera Vasquez C, Klamer B, Kallash M, Aldughiem A. Evidence of early diabetic nephropathy in pediatric type 1 diabetes. Front Endocrinol. 2021;12:669954. https:\/\/doi.org\/10.3389\/fendo.2021.669954.","journal-title":"Front Endocrinol"},{"issue":"3","key":"1749_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11892-018-0979-3","volume":"18","author":"S Subramanian","year":"2018","unstructured":"Subramanian S, Hirsch IB. Diabetic kidney disease: is there a role for glycemic variability? Curr Diab Rep. 2018;18(3):13. https:\/\/doi.org\/10.1007\/s11892-018-0979-3.","journal-title":"Curr Diab Rep"},{"issue":"3","key":"1749_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","volume":"7","author":"A Ceriello","year":"2019","unstructured":"Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2019;7(3):221\u201330. https:\/\/doi.org\/10.1016\/S2213-8587(18)30136-0.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"1749_CR18","doi-asserted-by":"publisher","first-page":"968","DOI":"10.2337\/diab.44.8.968","volume":"44","author":"The relationship of","year":"1995","unstructured":"The relationship of. Glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44(8):968\u201383.","journal-title":"Diabetes"},{"issue":"8","key":"1749_CR19","doi-asserted-by":"publisher","first-page":"e3047","DOI":"10.1002\/dmrr.3047","volume":"34","author":"A Nusca","year":"2018","unstructured":"Nusca A, Tuccinardi D, Albano M, et al. Glycemic variability in the development of cardiovascular complications in diabetes. Diabetes Metab Res Rev. 2018;34(8):e3047. https:\/\/doi.org\/10.1002\/dmrr.3047.","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"1749_CR20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.diabres.2008.07.015","volume":"82","author":"A Ceriello","year":"2008","unstructured":"Ceriello A, Esposito K, Piconi L, et al. Glucose peak and glucosespike: impact on endothelial function and oxidative stress. Diabetes Res Clin Pract. 2008;82(2):262\u20137. https:\/\/doi.org\/10.1016\/j.diabres.2008.07.015.","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"1749_CR21","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1084\/jem.20081188","volume":"205","author":"A El-Osta","year":"2008","unstructured":"El-Osta A, Brasacchio D, Yao D, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med. 2008;205(10):2409\u201317. https:\/\/doi.org\/10.1084\/jem.20081188.","journal-title":"J Exp Med"},{"issue":"Suppl 2","key":"1749_CR22","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.2337\/dc08-s241","volume":"31","author":"L Monnier","year":"2008","unstructured":"Monnier L, Colette C. Glycemic variability: should we and can we prevent it? Diabetes Care. 2008;31(Suppl 2):S150\u20134. https:\/\/doi.org\/10.2337\/dc08-s241.","journal-title":"Diabetes Care"},{"issue":"6","key":"1749_CR23","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2337\/diacare.21.6.1019","volume":"21","author":"L Barkai","year":"1998","unstructured":"Barkai L, V\u00e1mosi I, Luk\u00e1cs K. Enhanced progression of urinary albumin excretion in IDDM during puberty. Diabetes Care. 1998;21(6):1019\u201323. https:\/\/doi.org\/10.2337\/diacare.21.6.1019.","journal-title":"Diabetes Care"},{"key":"1749_CR24","doi-asserted-by":"publisher","first-page":"107781","DOI":"10.1016\/j.diabres.2019.07.005","volume":"155","author":"P Di Bonito","year":"2019","unstructured":"Di Bonito P, Mozzillo E, Esposito M, et al. Non-albuminuric reduced eGFR phenotype in children and adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2019;155:107781. https:\/\/doi.org\/10.1016\/j.diabres.2019.07.005.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"1749_CR25","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.numecd.2021.03.019","volume":"31","author":"P Di Bonito","year":"2021","unstructured":"Di Bonito P, Mozzillo E, Rosanio FM, et al. Albuminuric and non-albuminuric reduced eGFR phenotypes in youth with type 1 diabetes: factors associated with cardiometabolic risk. Nutr Metab Cardiovasc Dis. 2021;31(7):2033\u201341. https:\/\/doi.org\/10.1016\/j.numecd.2021.03.019.","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01749-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T01:32:05Z","timestamp":1748223125000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01749-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1749"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01749-x","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Central Ethics Committee, Budapest, Hungary (BM\/19256-2\/2024). Written informed consent to participate in this study was provided by the participants\u2019 legal guardian\/next of kin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}